|
1
|
Ferlay J, Shin HR, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lin CS, Lin YC, Adebayo BO, Wu A, Chen JH,
Peng YJ, Cheng MF, Lee WH, Hsiao M, Chao TY and Yeh CT: Silencing
JARID1B suppresses oncogenicity, stemness and increases radiation
sensitivity in human oral carcinoma. Cancer Lett. 368:36–45. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Cooper JS, Pajak TF, Forastiere AA, Jacobs
J, Campbell BH, Saxman SB, Kish JA, Kim HE, Cmelak AJ, Rotman M, et
al: Postoperative concurrent radiotherapy and chemotherapy for
high-risk squamous-cell carcinoma of the head and neck. N Engl J
Med. 350:1937–1944. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Blanchard P, Baujat B, Holostenco V,
Bourredjem A, Baey C, Bourhis J and Pignon JP; and MACH-CH
Collaborative group, . Meta-analysis of chemotherapy in head and
neck cancer (MACH-NC): A comprehensive analysis by tumour site.
Radiother Oncol. 100:33–40. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lin CS, Jen YM, Cheng MF, Lin YS, Su WF,
Hwang JM, Chang LP, Chao HL, Liu DW, Lin HY and Shum WY: Squamous
cell carcinoma of the buccal mucosa: An aggressive cancer requiring
multimodality treatment. Head Neck. 28:150–157. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lin CS, Jen YM, Kao WY, Ho CL, Dai MS,
Shih CL, Cheng JC, Chang PY, Huang WY and Su YF: Improved outcomes
in buccal squamous cell carcinoma. Head Neck. 35:65–71. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Machtay M, Moughan J, Trotti A, Garden AS,
Weber RS, Cooper JS, Forastiere A and Ang KK: Factors associated
with severe late toxicity after concurrent chemoradiation for
locally advanced head and neck cancer: An RTOG analysis. J Clin
Oncol. 26:3582–3589. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bjordal K, Hammerlid E, Ahlner-Elmqvist M,
de Graeff A, Boysen M, Evensen JF, Biörklund A, de Leeuw JR, Fayers
PM, Jannert M, et al: Quality of life in head and neck cancer
patients: Validation of the european organization for research and
treatment of cancer quality of life questionnaire-H&N35. J Clin
Oncol. 17:1008–1019. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Westra WH, Taube JM, Poeta ML, Begum S,
Sidransky D and Koch WM: Inverse relationship between human
papillomavirus-16 infection and disruptive p53 gene mutations in
squamous cell carcinoma of the head and neck. Clin Cancer Res.
14:366–369. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chera BS, Amdur RJ, Tepper J, Qaqish B,
Green R, Aumer SL, Hayes N, Weiss J, Grilley-Olson J, Zanation A,
et al: Phase 2 trial of De-intensified chemoradiation therapy for
favorable-risk human papillomavirus-associated oropharyngeal
squamous cell carcinoma. Int J Radiat Oncol Biol Phys. 93:976–985.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Watt SM, Buhring HJ, Rappold I, Chan JY,
Lee-Prudhoe J, Jones T, Zannettino AC, Simmons PJ, Doyonnas R,
Sheer D and Butler LH: CD164, a novel sialomucin on CD34(+) and
erythroid subsets, is located on human chromosome 6q21. Blood.
92:849–866. 1998.PubMed/NCBI
|
|
12
|
Doyonnas R, Chan Yi-Hsin J, Butler LH,
Rappold I, Lee-Prudhoe JE, Zannettino AC, Simmons PJ, Bühring HJ,
Levesque JP and Watt SM: CD164 monoclonal antibodies that block
hemopoietic progenitor cell adhesion and proliferation interact
with the first mucin domain of the CD164 receptor. J Immunol.
165:840–851. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kurosawa N, Kanemitsu Y, Matsui T, Shimada
K, Ishihama H and Muramatsu T: Genomic analysis of a murine
cell-surface sialomucin, MGC-24/CD164. Eur J Biochem. 265:466–472.
1999. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Watt SM, Butler LH, Tavian M, Bühring HJ,
Rappold I, Simmons PJ, Zannettino AC, Buck D, Fuchs A, Doyonnas R,
et al: Functionally defined CD164 epitopes are expressed on CD34(+)
cells throughout ontogeny but display distinct distribution
patterns in adult hematopoietic and nonhematopoietic tissues.
Blood. 95:3113–3124. 2000.PubMed/NCBI
|
|
15
|
Zannettino AC, Bühring HJ, Niutta S, Watt
SM, Benton MA and Simmons PJ: The sialomucin CD164 (MGC-24v) is an
adhesive glycoprotein expressed by human hematopoietic progenitors
and bone marrow stromal cells that serves as a potent negative
regulator of hematopoiesis. Blood. 92:2613–2628. 1998.PubMed/NCBI
|
|
16
|
Shi JA, Lu DL, Huang X and Tan W: miR-219
inhibits the proliferation, migration and invasion of
medulloblastoma cells by targeting CD164. Int J Mol Med.
34:237–243. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Tang J, Zhang L, She X, Zhou G, Yu F,
Xiang J and Li G: Inhibiting CD164 expression in colon cancer cell
line HCT116 leads to reduced cancer cell proliferation, mobility
and metastasis in vitro and in vivo. Cancer Invest. 30:380–389.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Havens AM, Jung Y, Sun YX, Wang J, Shah
RB, Bühring HJ, Pienta KJ and Taichman RS: The role of sialomucin
CD164 (MGC-24v or endolyn) in prostate cancer metastasis. BMC
Cancer. 6:1952006. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Guenova E, Ignatova D, Chang YT, Contassot
E, Mehra T, Saulite I, Navarini AA, Mitev V, Dummer R and Kazakov
DV: Expression of CD164 on malignant T cells in Sézary syndrome.
Acta Derm Venereol. 96:464–467. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wysocka M, Kossenkov AV, Benoit BM, Troxel
AB, Singer E, Schaffer A, Kim B, Dentchev T, Nagata S, Ise T, et
al: CD164 and FCRL3 are highly expressed on CD4+CD26- T cells in
Sézary syndrome patients. J Invest Dermatol. 134:229–236. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Huang AF, Chen MW, Huang SM, Kao CL, Lai
HC and Chan JY: CD164 regulates the tumorigenesis of ovarian
surface epithelial cells through the SDF-1α/CXCR4 axis. Mol Cancer.
12:1152013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Matsui T, Kurosawa N, Hibi K, Akiyama S,
Kasai Y, Sakamoto J, Ito K, Nakao A and Muramatsu T: The ratio of
splicing variants of MGC-24/CD164, a sialomucin, correlates with
the metastatic potential of colorectal carcinomas. J Biochem.
127:1103–1107. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Edge SB and Compton CC: The american joint
committee on cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Marcial VA, Pajak TF, Mohiuddin M, Cooper
JS, al Sarraf M, Mowry PA, Curran W, Crissman J, Rodríguez M and
Vélez-García E: Concomitant cisplatin chemotherapy and radiotherapy
in advanced mucosal squamous cell carcinoma of the head and neck.
Long-term results of the radiation therapy oncology group study
81–17. Cancer. 66:1861–1868. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
van den Bent MJ, van Putten WL, Hilkens
PH, de Wit R and van der Burg ME: Retreatment with dose-dense
weekly cisplatin after previous cisplatin chemotherapy is not
complicated by significant neuro-toxicity. Eur J Cancer.
38:387–391. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Mazieres J, Brugger W, Cappuzzo F, Middel
P, Frosch A, Bara I, Klingelschmitt G and Klughammer B: Evaluation
of EGFR protein expression by immunohistochemistry using H-score
and the magnification rule: Re-analysis of the SATURN study. Lung
Cancer. 82:231–237. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
McGuckin CP, Forraz N, Baradez MO,
Lojo-Rial C, Wertheim D, Whiting K, Watt SM and Pettengell R:
Colocalization analysis of sialomucins CD34 and CD164. Stem Cells.
21:162–170. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Jorgensen-Tye B, Levesque JP, Royle L,
Doyonnas R, Chan JY, Dwek RA, Rudd PM, Harvey DJ, Simmons PJ and
Watt SM: Epitope recognition of antibodies that define the
sialomucin, endolyn (CD164), a negative regulator of
haematopoiesis. Tissue Antigens. 65:220–239. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Chen AY and Myers JN: Cancer of the oral
cavity. Dis Mon. 47:275–361. 2001. View Article : Google Scholar : PubMed/NCBI
|
